CGON240920C40000
- 1.50
- 0.000.00%
CG Oncology Newsroom
HC Wainwright & Co. Reiterates Buy on CG Oncology, Maintains $75 Price Target
H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $75
H.C. Wainwright analyst Andres Y. Maldonado maintains $CG Oncology(CGON.US)$ with a buy rating, and maintains the target price at $75.According to TipRanks data, the analyst has a success rate of 50.8
Buy Rating Justified for CG Oncology's Cretostimogene Due to Superior Safety Profile and Competitive Efficacy
CG Oncology Surges 7%; Seen Benefitting From J&J Bladder Cancer Asset Data
Goldman Sachs Initiates CG Oncology(CGON.US) With Buy Rating, Announces Target Price $52
Goldman Sachs analyst Chris Shibutani initiates coverage on $CG Oncology(CGON.US)$ with a buy rating, and sets the target price at $52.According to TipRanks data, the analyst has a success rate of 45.
LifeSci Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $86
LifeSci Capital analyst Sam Slutsky maintains $CG Oncology(CGON.US)$ with a buy rating, and maintains the target price at $86.According to TipRanks data, the analyst has a success rate of 46.0% and
Buy Rating Affirmed for CG Oncology Amid Competitive Landscape and Strong Clinical Results
CG Oncology Insider Sold Shares Worth $23,000,089, According to a Recent SEC Filing
CG Oncology(CGON.US) Director Sells US$23 Million in Common Stock
$CG Oncology(CGON.US)$ Director Song Hong Fang sold 650.46K shares of common stock on Aug 29, 2024 at an average price of $35.36 for a total value of $23 million.Source: Announcement What is
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Form 144 | CG Oncology(CGON.US) Director Proposes to Sell 15 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 29, $CG Oncology(CGON.US)$ Director Unique Diamond Investments Ltd intends to sell 424.21K shares of its common stock on Aug 29, with a total market value of
Form 144 | CG Oncology(CGON.US) Director Proposes to Sell 8 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 29, $CG Oncology(CGON.US)$ Director Charming Jade Ltd intends to sell 226.25K shares of its common stock on Aug 29, with a total market value of approximately $8 million.
We're Not Very Worried About CG Oncology's (NASDAQ:CGON) Cash Burn Rate
Roth Starts CG Oncology at Buy, Cites Anticipated FDA Filing
CG Oncology Price Target Announced at $65.00/Share by Roth MKM
CG Oncology Initiated at Buy by Roth MKM
Roth MKM Initiates Coverage On CG Oncology With Buy Rating, Announces Price Target of $65
CG Oncology Analyst Ratings
Bullish CG Oncology Insiders Loaded Up On US$5.06m Of Stock
Morgan Stanley Keeps Their Buy Rating on CG Oncology, Inc. (CGON)